Entropion Treatment Market Trends

  • Report ID: 3777
  • Published Date: Dec 23, 2024
  • Report Format: PDF, PPT

Entropion Treatment Market Trends

Growth Drivers

  • Growing Population of Old-Adults - Entropion often only affects the lower eyelid and is more prevalent in older persons. In research of approximately 25,000 people over the age of 60, approximately 2% of patients had involutional entropion. The prevalence of entropion increased with age.

  • Rising Success Rate of Entropion Treatment -Transverse blepharotomy and marginal rotation is a popular treatment for entropion. Moreover, throughout ten days, the bolster and sutures are in place. For the treatment of upper and lower lid cicatricial entropion, this surgery has an 85% success rate.

  • Increased Use of Contact Lenses - A soft contact lens are used to correct the vision, that is compromised due to entropion affected eye. There are around 140 million contact lens wearers in the world. Out of which, nearly 45 million users are in the United States.

  • Rising Prevalence of Dry Eye Syndrome - Dry eye syndrome is a common symptom of entropion eye, it causes itchiness, dryness, and redness. A greater number of people are impacted by dry eyes and decreased tear production. Between 5 to 50 percent of people worldwide have a dry eye condition.

  • Rising Use of Eye Drops - Doctors prescribe the use of mild eye drops to avoid any irritation and redness in the eye. By 2020, at least 3 million people in the UK will use eye drops and ointments daily. Following this, about 2 million people began using eye drops and ointments less frequently than once per month.

Challenges

  • Complications related to eye surgeries - The majority of patients have brief side effects like edoema and bruising after entropion surgery. The market's growth is anticipated to be hampered by the growing concern over additional negative effects related to entropion surgery.
  • Lack of awareness regarding entropion and its treatment
  • High cost of cosmetic treatment for entropion

Entropion Treatment Market: Key Insights

Base Year

2022

Forecast Year

2023-2035

CAGR

~7%

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Base Year

2024

Forecast Year

2025-2037

CAGR

6.8%

Base Year Market Size (2024)

USD 456.57 million

Forecast Year Market Size (2037)

USD 1.07 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3777
  • Published Date: Dec 23, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of entropion treatment is assessed at USD 507.6 million.

The entropion treatment market size was over USD 456.57 million in 2024 and is projected to reach USD 1.07 billion by 2037, witnessing around 6.8% CAGR during the forecast period i.e., between 2025-2037. Increasing geriatric population, rising success of the entropion treatment, the growing popularity of contact lenses, and increasing cases of dry eye syndrome will drive the market growth.

North America industry is anticipated to hold largest revenue share by 2037, due to rising cases of entropion in older adults, and higher number of people suffering with dry eye issues.

The major players in the market are Eli Lilly and Company, Bausch & Lomb Incorporated, Sun Pharmaceutical Industries Ltd., Novartis AG, Sanofi-aventis Groupe, Abbott Laboratories, Merck & Co., Inc., Siemens Healthcare GmbH, Pfizer Inc., and Alembic Limited
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample